Previous Article | Next Article 
Journal of Virology, November 2000, p. 9818-9827, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mutations in the PPPY Motif of Vesicular Stomatitis
Virus Matrix Protein Reduce Virus Budding by Inhibiting a Late Step
in Virion Release
Himangi R.
Jayakar,1
K. Gopal
Murti,2 and
Michael A.
Whitt1,*
Department of Microbiology and Immunology,
University of Tennessee
Memphis, Memphis, Tennessee
38163,1 and Department of Virology and
Molecular Biology, St. Jude Children's Research Hospital, Memphis,
Tennessee 381012
Received 8 May 2000/Accepted 25 July 2000
 |
ABSTRACT |
The N terminus of the matrix (M) protein of vesicular stomatitis
virus (VSV) and of other rhabdoviruses contains a highly conserved PPPY
sequence (or PY motif) similar to the late (L) domains in the Gag
proteins of some retroviruses. These L domains in retroviral Gag
proteins are required for efficient release of virus particles. In this
report, we show that mutations in the PPPY sequence of the VSV M
protein reduce virus yield by blocking a late stage in virus budding.
We also observed a delay in the ability of mutant viruses to cause
inhibition of host gene expression compared to wild-type (WT) VSV. The
effect of PY mutations on virus budding appears to be due to a block at
a stage just prior to virion release, since electron microscopic
examination of PPPA mutant-infected cells showed a large number of
assembled virions at the plasma membrane trapped in the process of
budding. Deletion of the glycoprotein (G) in addition to these
mutations further reduced the virus yield to less than 1% of WT
levels, and very few particles were assembled at the cell surface. This
observation suggested that G protein aids in the initial stage of
budding, presumably during the formation of the bud site. Overall, our results confirm that the PPPY sequence of the VSV M protein possesses L
domain activity analogous to that of the retroviral Gag proteins.
 |
INTRODUCTION |
The assembly and budding of
enveloped negative-strand RNA viruses is a multistep process occurring
at the plasma membrane of a host cell. Vesicular stomatitis
virus (VSV), a prototype enveloped negative-strand RNA virus
belonging to the family Rhabdoviridae, has long been
utilized as a model for studying various steps in virus assembly and
budding. Assembly is initiated when the matrix protein (M) binds
to and condenses the nucleocapsid core into a tightly coiled helical
structure in association with the inner leaflet of the plasma membrane.
During budding, the condensed core becomes enveloped in a host-derived
membrane highly enriched with the viral glycoprotein (G) and
selectively depleted of most of the host proteins.
Recent studies have shown that while G protein contributes to high
levels of virus budding, virus assembly and release can occur in the
absence of G protein, but with reduced efficiency (28, 36, 37,
43). Thus, the condensed ribonucleocapsid core (RNP) complexed
with M protein is sufficient to initiate and drive rhabdovirus budding.
Also, in the absence of other viral proteins, VSV M protein can cause
budding of lipid vesicles into the surrounding medium (20).
In the case of rabies virus, deletion of M protein dramatically reduced
virus yields, more than 10,000 fold. The
M particles that were
produced were filamentous instead of having the characteristic bullet
shape, confirming the earlier reports of the contribution of M protein
to virus morphology (25, 30, 31).
Besides its role in virus assembly and budding, matrix protein also
mediates most of the cytopathic effects (CPE) attributed to VSV
infection (4, 6, 11, 38). Transient expression of M protein
alone can cause cell rounding by disorganization of microtubules and
intermediate filaments (24). It can also cause inhibition of
host-directed transcription (4, 5, 32). Recently it was
shown that VSV infection leads to the inactivation of transcription
factor II D (TFIID), resulting in inhibition of RNA polymerase
II-dependent transcription (48). A separate effect of M
protein on host gene expression involves inhibition of Ran
GTPase-mediated nuclear transport, although the exact mechanism of this
effect is not known (18). M protein-induced CPE are genetically separable from the function of M protein in viral assembly
(4), suggesting the existence of separate domains within M
protein that carry out its multiple functions.
Previous studies have revealed that M protein is present at the inner
surface of the plasma membrane of infected cells (3, 23,
27). Affinity labeling studies suggested that the N-terminal basic region of M protein was associated with the lipid bilayer (23). The N terminus of M protein also contains a PPPY
sequence that is conserved among the matrix proteins of many
rhabdoviruses (16, 17). This PPPY sequence closely resembles
the PY motif in the late (L) domain of the Gag protein of Rous sarcoma
virus (RSV), an avian retrovirus. The L domains of retroviruses are involved in the late stages of virus budding, specifically the fission
event resulting in virus release (45-47). The L domains identified in the Gag proteins of other retroviruses have different amino acid sequences, but they can functionally substitute for the L
domain of RSV and allow budding of chimeric particles (33, 35). The PPPY sequence in the RSV L domain matches the consensus proline-rich motif required for interaction with WW domains found in
several regulatory and signal transduction proteins (9, 10, 26,
34). This observation has led to the suggestion that the PY motif
in viral proteins may play a role in recruiting WW-containing cellular
proteins for the purpose of assembly and budding of virus particles at
the host membrane (12, 14).
Recently, it was suggested that the PY motif found in rhabdovirus M
proteins might function as a late domain and contribute to virus
budding (12). Alanine mutagenesis of the VSV PY motif drastically reduced the budding function of mutant proteins in an in
vitro budding assay (12). Furthermore, it was demonstrated that the PY motifs of both VSV and rabies virus M proteins can interact
with WW domains of certain cellular proteins in in vitro binding assays
(17). Together, these studies suggested that the PY motif
may be important in the budding of virus particles and that this
process may involve cellular proteins.
In this study we have examined the contribution of the PY motif to VSV
assembly and budding by recovering infectious virus containing point
mutations within the PPPY sequence of M protein. Our results show that
mutations in the PPPY motif reduced, but did not completely abolish,
virus budding. Electron microscopy revealed that the mutants were
blocked at a late stage of budding, apparently during the release of
mature virions from the cell surface. Thus our studies confirm that the
PPPY motif within VSV M protein is functionally similar to the L
domains found in retroviral Gag proteins.
 |
MATERIALS AND METHODS |
Plasmids and oligonucleotide-directed mutagenesis.
To
generate mutations within the PPPY motif of M protein of VSV (Indiana
serotype), we performed site-directed mutagenesis using an overlap
PCR-based strategy. Six different sense strand, mutagenic
oligonucleotides were synthesized containing the appropriate nucleotide
changes for the indicated amino acid substitutions and also containing
a silent mutation at nucleotide 2326 (G
A) which abolished the
EarI site in the M gene. Each of the mutagenic primers was
used in six separate PCRs together with a common antisense oligonucleotide downstream of the unique BglII site at
nucleotide 2542 (M-2542 primer) to generate PCR products from the
template pBS-MGF. The pBS-MGF plasmid carries a genomic sense RNA of
VSV (Indiana serotype) containing the M, G, and green fluorescent protein (GFP) genes (previously referred to as pBS-GMF)
(41). A schematic representation of the MGF minigenome is
shown in Fig. 1. In a separate reaction,
we used an antisense oligonucleotide that overlapped nucleotides 2320 to 2340 and a sense oligonucleotide complementary to the T7 terminator
region (T7 term-1 primer), which is 180 bp downstream of a unique
RsrII site (in the leader region), to amplify the 5' end of
the M gene. This PCR fragment overlapped the 5' ends of the mutated PCR
fragments. The PCR fragments were gel purified, each fragment carrying
the mutation was used with the overlapping nonmutagenic fragment as
templates, and the entire region was amplified using the M-2542 and T7
term-1 primers external to the PCR region. The resulting 500-bp PCR
fragments were gel purified, digested with RsrII and
BglII, and then used to replace the corresponding wild-type
(WT) region in the pBS-MGF plasmid. Colonies carrying the correct
plasmids were identified following digestion of miniprep DNA with
EarI. The plasmids were then sequenced using the dideoxy
sequencing method to ensure that only the specified mutations were
introduced during the PCR amplification.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of PPXY mutations in the MGF
minigenome. MGF stands for the M, G, and GFP minigenome.
l and t denote the leader and trailer sequences,
respectively. The hepatitis delta virus ribozyme sequence (HDV) and the
T7 terminator sequence ( T) are represented by hatched boxes. Arrows
indicate the direction of transcription for each gene. The solid box at
the 5' end of the M gene represents the N-terminal region of the matrix
protein including the PPXY motif, which is enlarged below. The
numbering shows the positions of amino acids with respect to the N
terminus of M protein. Alanine substitutions were made for the proline
and tyrosine residues either singly or in combinations. The name of
each mutant is listed on the right. WT stands for the wild-type
sequence of the PY motif in VSV M protein. The mutants were classified
into two groups, P and Y mutants, based on the severity of their
phenotypes.
|
|
Generation of full-length PPXY mutants.
Each of the six M
genes carrying the specified mutations was subcloned into a plasmid
encoding a modified VSV antigenome called
M-PLF. This is a
full-length VSV cDNA in which the M coding region was replaced with a
polylinker (PL) containing unique restriction sites (5'
AscI-XhoI-SmaI-EagI-AvrII
3'), while retaining the normal M gene transcriptional start and stop
sequences. In addition,
M-PLF has a non-VSV reporter gene encoding
GFP inserted between the G and L genes. The MGF mutants were digested
with RcaI located in the 5' untranslated region of the M
gene and MluI located in the 5' untranslated region of the G
gene. Because RcaI is not a unique site, the remainder of
the 5' end of the M gene was obtained by digesting the WT pVSV FL-2 (+)
(22) with XbaI located at the 3' end of the P
gene and RcaI. The fragments were then gel purified and used
in a three-way ligation to replace the corresponding region of
M-PLF, which was digested with XbaI and MluI.
Recovery of PPXY mutants.
Recoveries of the minigenome
mutants were performed as described previously (40) and
monitored by detecting expression of GFP from the reporter gene.
Full-length viruses were recovered from their cDNAs as described
previously (22) with the following modifications. Briefly,
BHK cells in 60-mm dishes were infected with vTF7-3 at a multiplicity
of infection (MOI) of 10 for 1 h at 31°C in serum-free
Dulbecco's modified Eagle's medium (DMEM) without penicillin and
streptomycin. The cells were then cotransfected with plasmids encoding
WT or mutant genomes together with 3, 5, and 1 µg of plasmids
encoding the N, P, and L proteins, respectively, in the presence of 10 µg of 1-
-D-arabinofuranosylcytosine (araC)/ml. The
supernatants were harvested 48 h posttransfection (p.i.), filtered
through a 0.22-µm-pore-size filter (Millipore-GS) to remove vaccinia
virus, and used to obtain plaque isolates from BHK cells. The mutations
were confirmed by direct sequencing of reverse transcription-PCR
(RT-PCR) amplification products generated using genomic RNA as the template.
Assembly and budding assay for PPXY mutants.
BHK-21 cells in
35-mm dishes were infected with either WT VSV or the mutant viruses at
an MOI of 10 for 1 h. Following the adsorption period, the
inoculum was removed, and the cells were washed three times with
serum-free DMEM to remove any unadsorbed virus and then incubated with
2 ml of the same medium at 37°C. At 7 h p.i., the medium was
removed and the cells were washed once with methionine-free DMEM. The
cells were then labeled with 50 µCi of [35S]methionine
in 1 ml of labeling medium (9 parts of Met-free DMEM plus 1 part of
DMEM plus 5% fetal bovine serum [FBS]), using protein-labeling mix
(Dupont, NEN) at 37°C for 8 h. At 15 h p.i., the
supernatants were harvested and clarified by centrifuging at 1,260 × g for 5 min. The virions were then pelleted from the
supernatant by ultracentrifugation through a 20% sucrose cushion (in
50 mM Tris-150 mM NaCl [pH 7.4]) at 45,000 rpm for 40 min in an
AH-650 swinging bucket rotor (Sorvall). The pellets were resuspended in
equal volumes of reducing sample buffer. One-tenth of each sample was resolved by electrophoresis on a sodium dodecyl sulfate (SDS)-10% polyacrylamide gel followed by autoradiography. The amounts of virus
released from the WT and mutant infected cells were determined by
quantitation of the amounts of N protein using the Storm 860 PhosphorImager and ImageQuant analytical software (both from Molecular Dynamics).
Growth kinetics of mutants.
BHK cells in 60-mm plates were
infected with either WT VSV or the PPXY mutants at an MOI of 10 by
adsorbing for 1 h at 37°C. The inoculum was removed, and
following three washes with serum-free DMEM, the cells were incubated
with 4 ml of DMEM plus 5% FBS at 37°C. At the designated time point,
an aliquot of the supernatant was removed and the amount of infectious
virus in the supernatant was determined by a standard plaque assay on
BHK cells.
Host protein shutoff assay.
BHK-21 cells in 35-mm dishes
were infected with WT or mutant viruses at an MOI of 10 at 31°C.
After 1 h, the inoculum was removed, and cells were washed twice
with medium and incubated with 2 ml of DMEM plus 5% FBS at 37°C. At
each time point, the medium was removed, and the cells were washed
twice with Met-free DMEM and then incubated for an additional 10 min in
the same medium. The cells were labeled for 15 min with 1 ml of
methionine-free DMEM containing 50 µCi of
[35S]methionine at 37°C. Following the pulse, the label
was removed and cells were lysed with 1 ml of detergent solution (10 mM
Tris [pH 7.4], 66 mM EDTA, 0.4% sodium deoxycholate, 1% Triton
X-100, 0.05% sodium azide, and 200 U of aprotinin/ml). Cell extracts were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) followed
by autoradiography. The degree of host shutoff was determined by
quantitating the amount of 35S-labeled host proteins
present in a small area of the gel mostly devoid of viral proteins by
using a Storm 860 Phosphorimager (Molecular Dynamics). The shutoff of
host protein synthesis was expressed as the percentage of the amount of
total labeled host proteins in the uninfected sample (MOCK) detected at
given time points in the assay.
Transmission electron microscopy.
BHK-21 cells were infected
with either the WT or mutant viruses for 8 h at 37°C. Following
infection, the cells were harvested and washed three times with
phosphate-buffered saline (PBS). They were then fixed with 2%
glutaraldehyde in PBS and postfixed with 1% osmium tetroxide
(29). The fixed cells were dehydrated in a graded series of
ethyl alcohol, stained with uranyl acetate, and embedded in Spurr
resin. Ultrathin sections were cut on a Sorvall MT6000 ultramicrotome,
and the sections were stained with Reynold's lead citrate before
examination within a JEOL 1200 electron microscope.
Scanning electron microscopy.
BHK-21 cells were grown on
plastic coverslips (Thermanox; Nunc) that were placed in six-well
culture plates (Costar) and infected with WT and PPPA mutant viruses at
an MOI of 10. At 8 h p.i., cells were rinsed with PBS, fixed with
5% glutaraldehyde in PBS, and postfixed with 2% osmium tetroxide in
PBS. After dehydration in a graded series of ethanols, the cells were
dried out with hexamethyldisilazane, coated with gold in a
sputter-coater, and examined in the scanning mode of a JEOL 1200 EX II
TEMscan electron microscope.
 |
RESULTS |
The PPXY motif is important but not essential for VSV budding.
A recent report by Harty et al. (17) suggested that the PPPY
motif in VSV matrix (M) protein might be important for virus assembly
and release, since mutations in this motif greatly reduced M-induced
vesicle budding. To determine whether the PPXY motif was essential for
the budding of virus particles, we first made use of a minigenome
system (39). The minigenome used in this study was called
MGF and consisted of genes encoding matrix protein (M) and glycoprotein
(G) as well as a non-VSV reporter gene encoding GFP. Alanine
substitutions were made either singly or in various combinations within
the PPXY motif of the matrix protein (Fig. 1). If the PPXY motif was
absolutely critical for virus budding, then the alanine substitutions
would result in only single cells expressing M, G, and GFP, but no
virus spread would occur. However, we found that none of the point
mutations prevented the release and spread of infectious minivirus
(data not shown).
Recovery and characterization of infectious full-length PPXY
mutants.
To obtain a more quantitative evaluation of the
effect of mutations in the PPPY sequence, the mutations were subcloned
into a modified full-length VSV cDNA (pVSV-GFP) that encodes GFP as a
reporter gene. This construct will be referred to as WT in the subsequent experiments. The GFP gene was cloned between the G and L
genes, making L the sixth gene. All of the PPXY mutants were recovered
and could be passaged in cell culture, which supported our observations
from the minigenome system. To determine the effects of the mutations
on virus replication and budding, we analyzed the amount of virus
released from cells infected with mutant viruses. Cells were infected
with either the WT or the mutants, and the virus released in the
culture media was analyzed by SDS-PAGE followed by autoradiography
(Fig. 2). The mobilities of the five
viral proteins were indistinguishable in the WT and mutant viruses, and
all five VSV proteins were present in the mutant virions in similar
proportions to that found in WT virus. However, the amount of virus
released from the mutant infected cells, except for the PPAY mutant,
was only 20% of that released from WT-infected cells. In comparison,
cells infected with the PPAY mutant released virus at approximately
50% of the WT level. The reduced budding could not be relieved by
growing the viruses at 31°C, indicating that the mutants were not
temperature sensitive (data not shown). The plaque sizes of all
mutants, except PPAY, were also smaller than that of the WT (Fig.
3A). Plaques formed by the AAPA mutant
were about half the size of WT virus plaques (Fig. 3B) and never
attained the size of WT plaques even after 48 h of incubation
(data not shown). The plaque size of the PPAY mutant was about 80%
that of the WT.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 2.
Assembly and budding profile of PPXY mutants. BHK-21
cells were infected with either the WT or mutant viruses at an MOI of
10. Cells were labeled at 7 h p.i. with
[35S]methionine. At 15 h p.i., viruses were
harvested from the supernatants by centrifugation and analyzed by
SDS-PAGE followed by autoradiography. The positions of the five VSV
proteins are indicated on the right. The mutated residue(s) in the PPPY
sequence of each mutant is underlined. The percent yield of virus in
this experiment is calculated based on the quantitation of N protein
using ImageQuant software (Molecular Dynamics).
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the plaque sizes of WT and PPXY mutants in
BHK-21 cells. (A) A standard plaque assay was performed for each virus
on BHK-21 cells. At 13 h p.i., the sizes of 25 individual plaques
were determined for each virus. The mean plaque size for each virus is
shown. The residue(s) changed in each mutant is underlined. (B)
Fluorescence micrograph of GFP-expressing cells comparing the plaque
sizes of WT and the PPPA mutant (magnification, ×7.5).
|
|
Growth curve of PPXY mutants.
We also performed one-step
growth curves for each of the mutants as well as the WT virus (Fig.
4). The results show that there is a
delay in virus release at early time points for all mutants except PPAY
compared to the WT virus. The effect was more pronounced for the Y
(APPA, AAPA, and
PPPA) mutants compared to the P (APPY and
AAPY) mutants. The delay was not relieved by performing the experiment at either a lower temperature (31°C) or a higher MOI (MOI,
50) (data not shown). The PPAY mutant, as expected, had growth kinetics
similar to that of the WT virus, which correlates well with the
observation that the third proline residue in this motif is not
conserved among rhabdoviruses and therefore does not contribute
significantly to the function of this motif.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 4.
Growth kinetics of PPXY mutants in BHK-21 cells. BHK-21
cells were infected with either the WT or the mutant viruses at an MOI
of 10. At various times p.i., aliquots of supernatant were taken to
determine the titer by a plaque assay on BHK cells. The kinetics for
the P and Y mutants were determined simultaneously under similar
conditions, but they were plotted individually to show the growth
difference during early times of infection.
|
|
Morphogenesis of the PPPY mutants.
The above results indicated
that the ability of the PPPY mutants to produce virus was affected.
There are several possibilities which could explain the phenotype of
these mutants. The mutations could inhibit (i) the association of M
with RNPs, (ii) the association of RNP-M complexes with the plasma
membrane, or (iii) virus release from the cell surface. To distinguish
between these possibilities, thin-section electron-microscopic analysis
was performed on BHK cells infected with either the WT or the mutant
viruses. Thin sections of cells infected with WT virus or
G virus
(virus lacking G), each of which has an intact PPPY sequence, had
predominantly mature extracellular virions present (Fig.
5A and B). However, electron micrographs
of cells infected with the AAPY or the AAPA mutant showed a larger
proportion of virions assembled at the cell surface, apparently in the
process of budding (Fig. 5C and D). Quantification of the budding
virions revealed a threefold increase in the number of AAPY and AAPA
mutant virions that were not yet released from the plasma membrane
(e.g., budding) compared to the WT or the
G virions (Table
1). Therefore, these mutants were able to
condense RNP cores and associate with the plasma membrane similarly to
WT virus, but it appeared that virus release was inhibited and
consequently virions accumulated on the cell surface. This is very
clearly seen in the scanning electron micrographs shown in Fig.
6. Uninfected BHK cells have microvilli
projecting from an otherwise smooth cell surface (Fig. 6A and D). Cells
infected with WT virus showed only a few virions budding from the cell (Fig. 6B and E). On the other hand, the entire surface of the cell
infected with the PPPA mutant was covered with virions presumably trapped in the process of budding (Fig. 6C and F). Thus, the PPPY sequence appears to be involved in the late budding step of virus morphogenesis, most likely the pinching off of mature virions from the
cell surface which is analogous to the L domain activity in the
retroviral Gag proteins.

View larger version (140K):
[in this window]
[in a new window]
|
FIG. 5.
Electron micrographs showing morphologies of PPXY
mutants. BHK-21 cells infected with WT or mutant viruses were fixed at
8 h p.i., and thin sections of cells were examined under the
electron microscope to determine the stage(s) at which morphogenesis of
PPXY mutants was blocked. (A) WT; (B) G-GFP; (C) AAPY; (D and E)
PPPA; (F) G-AAPA. Magnifications: ×15,000 for panels A through D;
×18,000 for panel F. Panel E) is an enlargement of panel D. Arrows in
panel E point to the budding virions attached to the plasma membrane of
the infected cell.
|
|

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 6.
Scanning electron micrographs of WT virus and the PPPA
mutant. BHK-21 cells on plastic coverslips were infected with either WT
virus or the PPPA mutant at an MOI of 10. At 8 h p.i., cells were
fixed and processed as described in Materials and Methods. (A and D)
Uninfected cells; (B and E) WT infected cells; (C and F) PPPA
mutant-infected cells. Magnifications: ×4,000 for panels A through C;
×12,000 for panels D through F.
|
|
Effects of the PPXY mutations in the absence of glycoprotein.
Because the mutations in the PPPY sequence did not completely abolish
virus budding, the residual budding activity could be attributed to
another region(s) in M or to spontaneous release of virus accumulated
at the cell surface over time. Alternatively, G protein may affect
virus release either by acting in concert with the PPXY motif of M
protein or by acting alone. To assess the role of G protein in the
budding process, we recovered an AAPA mutant that lacked G protein
(
G-AAPA) and performed a similar analysis of virus assembly and
release. If G contributes to virus release, then in
G-AAPA infected
cells, all virions would be trapped at the cell surface in the process
of budding and very few, if any, would be released into the medium. As
shown in Fig. 7,
G-AAPA was severely
affected in its ability to produce virus; less than 1% of virus was
released compared to WT-VSV, even though the mutant infected cells
synthesized WT levels of viral proteins (data not shown). However,
thin-section electron microscopy indicated that in the absence of G
protein, fewer particles were assembled at the surface, and of those
that did, most were not released (Fig. 5F). Thus, G protein does not
account for the low levels of virions released from the PPXY mutants;
instead, it appears that G protein is involved in an early stage of
virus budding prior to the step of virion release.

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 7.
Assembly phenotype of AAPA mutant in the absence of
glycoprotein. Virions released from cells infected with either G-GFP
or G-PPPA were compared to those released from WT-infected cells.
Virions were prepared and analyzed on SDS-polyacrylamide gels as
described for Fig. 2. (A) WT; (B) G-GFP; (C) G-PPPA; (D and E)
longer exposures of panels B and C.
|
|
Inhibition of host protein synthesis by PPXY mutants.
In
addition to its role in the assembly and budding of virus, matrix
protein has been shown to cause cell rounding and inhibition of host
gene expression. However, relatively little is known about the regions
of M protein involved in these CPE. Therefore, we wanted to determine
whether the mutations in the PPXY motif would have any effect on viral
cytopathogenesis. Examination of cells by phase-contrast microscopy
indicated that the extent as well as the kinetics of cell rounding in
BHK cells was unaltered during infection by mutants (data not shown).
We also examined whether there was any difference in the ability of the
mutants to inhibit host cell gene expression. BHK cells were infected
with either the WT virus or mutant viruses and then pulse-labeled with
[35S]methionine at several times p.i. The crude cell
lysates were then analyzed by SDS-PAGE as described previously
(21). We found that the kinetics of host shutoff was delayed
at early times p.i. compared to that for WT virus (Fig.
8). WT virus caused rapid inhibition of
host gene expression, with >90% inhibition seen by 6 h p.i. In
contrast, this level of inhibition was not seen until approximately
8 h p.i. with the mutants, and the delayed host shutoff effect was
not relieved by using a higher MOI (MOI, 50) (Fig. 8, inset panel C).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 8.
Kinetics of host protein synthesis shutoff by the AAPA
mutant. Cells were infected with either WT virus or the AAPA mutant
(MUT) virus at an MOI of 10. At the times indicated, the cells were
pulse-labeled for 15 min with [35S]methionine and lysed
in detergent buffer. A portion of the cell lysate was analyzed by
SDS-PAGE followed by autoradiography. Labeled uninfected cells (MOCK)
served as a control. (B) The amount of 35S-labeled host
proteins in each lane was determined by quantitating a representative
area on the gel (indicated by the asterisk in panel A) with a STORM
Phosphorimager and ImageQuant software (Molecular Dynamics). The amount
of host proteins in the uninfected cells (control) was considered to be
100%. The extent of host shutoff was expressed as a percentage of the
amount of host proteins in the control. The extent of host shutoff
caused by the AAPA mutant at an MOI of 50 is shown in the inset (C).
|
|
 |
DISCUSSION |
Recently it was shown that the N-terminal 74 amino acids of VSV M
protein containing the PPPY sequence could functionally replace the L
domain in the Gag protein of RSV (12). Deletion or point
mutations in this motif drastically reduced the budding activity of the
M-Gag chimeras in a transient expression system. Based on these
results, it was suggested that the PPPY motif might be the putative L
domain of VSV M protein, functioning in a similar fashion to the L
domains of retroviral Gag proteins. In this report we have analyzed the
effects of mutations in the PPPY sequence found in the N terminus of
VSV M protein on virus assembly and budding. All PPPY mutants
synthesized WT levels of all viral proteins in the infected cells (Fig.
8). They also appeared to condense RNP cores normally, since the
virions had the characteristic bullet-shaped morphology, similar to
that of WT particles. The virions assembled at the plasma membrane,
indicating that there was no defect in the association of condensed
RNPs with the plasma membrane. However, the final stage of budding,
i.e., the release of particles from the cell surface, was inefficient
in these mutants. Transmission electron microscopy of mutant-infected
cells showed a large number of virions at the cell surface apparently
trapped in the process of budding compared to the WT virus. This is
more dramatically seen in the scanning electron micrographs, wherein
the entire surface of the mutant-infected cell is covered with such
trapped virion particles. Based on these micrographs, it appears that VSV budding is not restricted to a specific region on the cell surface,
at least under the experimental conditions used here.
Of all the mutants generated, the PPAY mutant gave the least severe
phenotype; this mutant showed growth kinetics similar to that of the WT
and gave virus yields about 50% of WT levels. This was not surprising,
since the third proline residue is the least conserved in this motif
among all the rhabdoviruses compared to date (17). While
low levels of virions were obtained for all the other mutants
(approximately 15 to 20% of WT levels), we found a more pronounced lag
during early times of virus infection for mutants with tyrosine
substitutions, either singly or in conjunction with the first or second
proline (Y mutants). These results suggest that the tyrosine residue is
particularly important for the function of this motif. A similar delay
in the kinetics of budding was observed for the RSV AD2 mutants lacking
the PPPYV sequence (45). A more severe phenotype was
observed for the PY mutants of Mason-Pfizer monkey virus (M-PMV),
wherein no virus particles were detected in the culture medium of cells
infected with a tyrosine mutant (47). The differences in the
severity of the phenotypes of the Y mutants in VSV and M-PMV indicate
that the mechanism of budding for rhabdoviruses, though similar in many
ways to those of retroviruses, has its own unique features.
Although disrupting the motif caused most of the virus particles to be
trapped at the cell surface, it did not completely block the release of
virus (20% of virus was still released from the cell). This leaky
phenotype has been observed for some late domain mutants in RSV (except
Y mutants) and M-PMV. The leakiness may be due to a spontaneous release
of some particles from the cell surface. Alternatively, the amount of
budding observed could also be attributed to redundant signals in M
protein, as suggested earlier (17).
The
G-AAPA mutant, which lacks the glycoprotein in addition to
having a mutated PPPY sequence, showed a drastically reduced virus
yield, releasing less than 1% of WT levels. The electron micrographs
of
G-AAPA mutant-infected cells showed very few particles at the
plasma membrane; most of these seemed to be trapped in the process of
pinching off from the cell surface (Fig. 5F). On the other hand, a
G-VSV virus that has an intact PPXY motif was rapidly released into
the extracellular milieu, similarly to the WT virus (Fig. 5A and B).
Thus it appears that in the absence of G protein, few virus particles
are able to assemble at the cell surface, and when the absence of G
protein is combined with the AAPA mutations, those particles that do
assemble are not released. Based on these observations, we propose that
G protein does not influence virion release per se but instead is
involved at an earlier step in budding. The recent observation that a
very short domain in the membrane proximal "stem" region of the
ectodomain of VSV-G protein can confer efficient virus assembly and
budding suggests that only a portion of G is sufficient for this event (36). Therefore, it will be interesting to determine if the stem region can rescue the
G-AAPA mutant and restore its phenotype to that of the AAPA mutant.
The polyproline sequence containing the core consensus of XPPXY was
first identified as the main ligand for the WW domain, a protein
interaction module found in a variety of cytoskeletal and regulatory
proteins (2, 7, 8, 10, 19, 42). Subsequently, the
identification of a conserved PPXY motif in several retroviruses
(45, 47), and recently in the matrix proteins of
rhabdoviruses (17), has led to a working hypothesis that the
PPXY motif, or its functional analogues in the L domain of viruses,
serves to bind cellular proteins containing WW domains, thereby
recruiting them to the site of virus budding (12, 14). It
was reported previously that amino acids 17 to 33 in VSV M protein,
which includes the PY motif, mediate interaction with WW domains of
specific cellular proteins, and point mutations in this motif
significantly decreased this binding as measured in an in vitro
far-Western blotting assay (17). Since the PPPY mutants have
a leaky phenotype, it appears that there might be an alternative way of
recruiting these cellular proteins to the budding site. Another
possibility is that the mutations in the PPPY sequence did not
completely abrogate binding to WW domains, but affected the affinity of
binding. This possibility is supported by the data obtained from the
solution structure of the WW domain of Yap65 complexed with a synthetic
polyproline peptide containing the core motif PPXY (26). The
mutants did not have an altered two-dimensional structure, but the
binding affinities changed depending on the residue altered, with the
tyrosine substitution having the most severe binding defect. Reduced
binding affinity could therefore lead to recruitment of fewer molecules
of host proteins, thus accounting for the low level of virus release in these mutants.
Our experiments also revealed that the disruption of the PPPY sequence
affected the kinetics of host shutoff in the infected cells. The
tyrosine mutants showed a delay in the inhibition of host gene
expression, which was not relieved by infection at a higher
multiplicity (Fig. 8C). This defect could reflect a general impairment
of M protein function because of incorrect conformation caused by
replacement of an aromatic residue (tyrosine) with a nonaromatic
hydrophobic residue (alanine). However, cell rounding was unaffected,
suggesting that it may not be the conformational change which is
affecting the host shutoff ability. An alternative explanation could be
that a specific interaction(s) between the M protein and the host
factors resulting in the host shutoff might have been affected. The
ability of M protein to inhibit RNA polymerase (RNAP) II-dependent
transcription has been well recognized (1, 4, 13, 18, 32).
It was also shown that M protein inhibits nuclear import of
transcription factors in VSV-infected cells (18). This
effect is separate from the inhibition of host transcription by
inactivation of TFIID, since the levels of TFIID in the nuclear extracts of infected cells remain unchanged (48). The
inhibition of TFIID activity is proposed to be an indirect effect of M
protein, since nuclear extracts from VSV-infected cells as well as
purified M protein failed to cause a reproducible inhibition of TFIID
activity (48). It has been demonstrated that the function of
M protein in viral assembly is genetically separable from its role in
the inhibition of host-directed expression (5). This
suggests that there might be different domains within M protein which
mediate these different functions. Although the activity of viral
assembly has been largely associated with N-terminal sequences of the
protein, the domains involved in viral cytopathogenesis have not yet
been identified. The effect of PY mutations on the inhibition of host gene expression suggests that this motif might be involved in this
activity of the protein. Sequence analysis shows that the RNAP II
C-terminal domain (CTD) contains several PY motifs with a consensus
"XSPXY". It has been shown that the CTD of mammalian RNAP II binds
efficiently to the YAP WW domains as well as to mNEDD4-WW2, the
mammalian homologue of the ubiquitin ligase Rsp5 in a far-Western assay
(15). Interestingly, the WW domains from YAP and Nedd4 also
interacted strongly and specifically with the PY motifs of both VSV and
rabies virus M proteins (17). This coincidental observation
suggests that VSV M protein may indirectly associate with the CTD of
RNAP II via one or more of these WW-containing proteins. Alternatively,
the PPPY sequence in M protein may disrupt the interaction between the
RNAP II CTD and YAP or Yap-like proteins, thereby interfering in one or
more signaling pathways. The mutations in the PY motif may therefore
affect such an action of M protein. However, the effect was not very
drastic, suggesting again that there might be more than one region of M
protein involved in its cytopathic role. The implication of such a
potential association between M protein and RNAP II for the inhibition
of host gene expression needs to be addressed in order to enhance our
understanding of how M protein contributes to the different CPE during
VSV infection.
 |
ACKNOWLEDGMENTS |
We greatly appreciate the technical assistance of Carolyn
Matthews (UT Memphis) and Donna Davis (St. Jude Children's Research Hospital). We thank Tim Higgins for assistance in figure preparation. We also thank Clint Robison, Eswaraka Jeetendra, and Indrani Halder for
helpful comments after reading the manuscript. Oligonucleotides were
synthesized by the Molecular Resource Center (MRC) at the University of
Tennessee at Memphis.
This work was supported by NIH grant GM-53726 to M.A.W.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, College of Medicine, University of
Tennessee
Memphis, 858 Madison Ave., Memphis, TN 38163. Phone: (901)
448-4634. Fax: (901) 448-8462. E-mail: mwhitt{at}utmem.edu.
 |
REFERENCES |
| 1.
|
Ahmed, M., and D. S. Lyles.
1997.
Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
Virology
237:378-388[CrossRef][Medline].
|
| 2.
|
Andre, B., and J. Y. Springael.
1994.
WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yes-associated protein YAP65.
Biochem. Biophys. Res. Commun.
205:1201-1205[CrossRef][Medline].
|
| 3.
|
Bergmann, J. E., and P. J. Fusco.
1988.
The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein.
J. Cell Biol.
107:1707-1715[Abstract/Free Full Text].
|
| 4.
|
Black, B. L., and D. S. Lyles.
1992.
Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo.
J. Virol.
66:4058-4064[Abstract/Free Full Text].
|
| 5.
|
Black, B. L.,
R. B. Rhodes,
M. McKenzie, and D. S. Lyles.
1993.
The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.
J. Virol.
67:4814-4821[Abstract/Free Full Text].
|
| 6.
|
Blondel, D.,
G. G. Harmison, and M. Schubert.
1990.
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.
J. Virol.
64:1716-1725[Abstract/Free Full Text].
|
| 7.
|
Bork, P., and M. Sudol.
1994.
The WW domain: a signalling site in dystrophin?
Trends Biochem. Sci.
19:531-533[CrossRef][Medline].
|
| 8.
|
Chan, D. C.,
M. T. Bedford, and P. Leder.
1996.
Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
EMBO J.
15:1045-1054[Medline].
|
| 9.
|
Chen, H. I.,
A. Einbond,
S. J. Kwak,
H. Linn,
E. Koepf,
S. Peterson,
J. W. Kelly, and M. Sudol.
1997.
Characterization of the WW domain of human Yes-associated protein and its polyproline-containing ligands.
J. Biol. Chem.
272:17070-17077[Abstract/Free Full Text].
|
| 10.
|
Chen, H. I., and M. Sudol.
1995.
The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.
Proc. Natl. Acad. Sci. USA
92:7819-7823[Abstract/Free Full Text].
|
| 11.
|
Coulon, P.,
V. Deutsch,
F. Lafay,
C. Martinet Edelist,
F. Wyers,
R. C. Herman, and A. Flamand.
1990.
Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus.
J. Gen. Virol.
71:991-996[Abstract/Free Full Text].
|
| 12.
|
Craven, R. C.,
R. N. Harty,
J. Paragas,
P. Palese, and J. W. Wills.
1999.
Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras.
J. Virol.
73:3359-3365[Abstract/Free Full Text].
|
| 13.
|
Ferran, M. C., and J. M. Lucas Lenard.
1997.
The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
J. Virol.
71:371-377[Abstract].
|
| 14.
|
Garnier, L.,
J. W. Wills,
M. F. Verderame, and M. Sudol.
1996.
WW domains and retrovirus budding.
Nature
381:744-745[CrossRef][Medline].
|
| 15.
|
Gavva, N. R.,
R. Gavva,
K. Ermekova,
M. Sudol, and C. J. Shen.
1997.
Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II.
J. Biol. Chem.
272:24105-24108[Abstract/Free Full Text].
|
| 16.
|
Gill, D. S., and A. K. Banerjee.
1986.
Complete nucleotide sequence of the matrix protein mRNA of vesicular stomatitis virus (New Jersey serotype).
Virology
150:308-312[CrossRef][Medline].
|
| 17.
|
Harty, R. N.,
J. Paragas,
M. Sudol, and P. Palese.
1999.
A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding.
J. Virol.
73:2921-2929[Abstract/Free Full Text].
|
| 18.
|
Her, L. S.,
E. Lund, and J. E. Dahlberg.
1997.
Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus.
Science
276:1845-1848[Abstract/Free Full Text].
|
| 19.
|
Hofmann, K., and P. Bucher.
1995.
The rsp5-domain is shared by proteins of diverse functions.
FEBS Lett.
358:153-157[CrossRef][Medline].
|
| 20.
|
Justice, P. A.,
W. Sun,
Y. Li,
Z. Ye,
P. R. Grigera, and R. R. Wagner.
1995.
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus.
J. Virol.
69:3156-3160[Abstract].
|
| 21.
|
Kretzschmar, E.,
R. Peluso,
M. J. Schnell,
M. A. Whitt, and J. K. Rose.
1996.
Normal replication of vesicular stomatitis virus without C proteins.
Virology
216:309-316[CrossRef][Medline].
|
| 22.
|
Lawson, N. D.,
E. A. Stillman,
M. A. Whitt, and J. K. Rose.
1995.
Recombinant vesicular stomatitis viruses from DNA.
Proc. Natl. Acad. Sci. USA
92:4477-4481[Abstract/Free Full Text].
|
| 23.
|
Lenard, J., and R. Vanderoef.
1990.
Localization of the membrane-associated region of vesicular stomatitis virus M protein at the N terminus, using the hydrophobic, photoreactive probe 125I-TID.
J. Virol.
64:3486-3491[Abstract/Free Full Text].
|
| 24.
|
Lyles, D. S., and M. O. McKenzie.
1997.
Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
Virology
229:77-89[CrossRef][Medline].
|
| 25.
|
Lyles, D. S.,
M. O. McKenzie,
P. E. Kaptur,
K. W. Grant, and W. G. Jerome.
1996.
Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes.
Virology
217:76-87[CrossRef][Medline].
|
| 26.
|
Macias, M. J.,
M. Hyvonen,
E. Baraldi,
J. Schultz,
M. Sudol,
M. Saraste, and H. Oschkinat.
1996.
Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide.
Nature
382:646-649[CrossRef][Medline].
|
| 27.
|
McCreedy, B. J., Jr., and D. S. Lyles.
1989.
Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected cell plasma membranes.
Virus Res.
14:189-205[CrossRef][Medline].
|
| 28.
|
Mebatsion, T.,
M. Konig, and K. K. Conzelmann.
1996.
Budding of rabies virus particles in the absence of the spike glycoprotein.
Cell
84:941-951[CrossRef][Medline].
|
| 29.
|
Murti, K. G.,
P. S. Brown,
M. Kumagai, and D. Campana.
1996.
Molecular interactions between human B-cell progenitors and the bone marrow microenvironment.
Exp. Cell Res.
226:47-58[CrossRef][Medline].
|
| 30.
|
Newcomb, W. W., and J. C. Brown.
1981.
Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions.
J. Virol.
39:295-299[Abstract/Free Full Text].
|
| 31.
|
Newcomb, W. W.,
G. J. Tobin,
J. J. McGowan, and J. C. Brown.
1982.
In vitro reassembly of vesicular stomatitis virus skeletons.
J. Virol.
41:1055-1062[Abstract/Free Full Text].
|
| 32.
|
Paik, S. Y.,
A. C. Banerjea,
G. G. Harmison,
C. J. Chen, and M. Schubert.
1995.
Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.
J. Virol.
69:3529-3537[Abstract].
|
| 33.
|
Parent, L. J.,
C. B. Wilson,
M. D. Resh, and J. W. Wills.
1996.
Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.
J. Virol.
70:1016-1026[Abstract].
|
| 34.
|
Pirozzi, G.,
S. J. McConnell,
A. J. Uveges,
J. M. Carter,
A. B. Sparks,
B. K. Kay, and D. M. Fowlkes.
1997.
Identification of novel human WW domain-containing proteins by cloning of ligand targets.
J. Biol. Chem.
272:14611-14616[Abstract/Free Full Text].
|
| 35.
|
Puffer, B. A.,
L. J. Parent,
J. W. Wills, and R. C. Montelaro.
1997.
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
J. Virol.
71:6541-6546[Abstract].
|
| 36.
|
Robison, C. S., and M. A. Whitt.
2000.
The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.
J. Virol.
74:2239-2246[Abstract/Free Full Text].
|
| 37.
|
Schnell, M. J.,
J. E. Johnson,
L. Buonocore, and J. K. Rose.
1997.
Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection.
Cell
90:849-857[CrossRef][Medline].
|
| 38.
|
Simon, K. O.,
P. A. Whitaker-Dowling,
J. S. Youngner, and C. C. Widnell.
1990.
Sequential disassembly of the cytoskeleton in BHK21 cells infected with vesicular stomatitis virus.
Virology
177:289-297[CrossRef][Medline].
|
| 39.
|
Stillman, E. A.,
J. K. Rose, and M. A. Whitt.
1995.
Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.
J. Virol.
69:2946-2953[Abstract].
|
| 40.
|
Stillman, E. A., and M. A. Whitt.
1997.
Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.
J. Virol.
71:2127-2137[Abstract].
|
| 41.
|
Stillman, E. A., and M. A. Whitt.
1999.
Transcript initiation and 5'-end modifications are separable events during vesicular stomatitis virus transcription.
J. Virol.
73:7199-7209[Abstract/Free Full Text].
|
| 42.
|
Sudol, M.,
H. I. Chen,
C. Bougeret,
A. Einbond, and P. Bork.
1995.
Characterization of a novel protein-binding module the WW domain.
FEBS Lett.
369:67-71[CrossRef][Medline].
|
| 43.
|
Takada, A.,
C. Robison,
H. Goto,
A. Sanchez,
K. G. Murti,
M. A. Whitt, and Y. Kawaoka.
1997.
A system for functional analysis of Ebola virus glycoprotein.
Proc. Natl. Acad. Sci. USA
94:14764-14769[Abstract/Free Full Text].
|
| 44.
|
Whitt, M. A.,
L. Buonocore,
J. K. Rose,
V. Ciccarone,
A. Chytil, and G. Gebeyehu.
1991.
TransfectACE reagent: transient transfection frequencies greater than 90%.
Focus
13:8-12.
|
| 45.
|
Wills, J. W.,
C. E. Cameron,
C. B. Wilson,
Y. Xiang,
R. P. Bennett, and J. Leis.
1994.
An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
J. Virol.
68:6605-6618[Abstract/Free Full Text].
|
| 46.
|
Xiang, Y.,
C. E. Cameron,
J. W. Wills, and J. Leis.
1996.
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.
J. Virol.
70:5695-5700[Abstract/Free Full Text].
|
| 47.
|
Yasuda, J., and E. Hunter.
1998.
A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.
J. Virol.
72:4095-4103[Abstract/Free Full Text].
|
| 48.
|
Yuan, H.,
B. K. Yoza, and D. S. Lyles.
1998.
Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID.
Virology
251:383-392[CrossRef][Medline].
|
Journal of Virology, November 2000, p. 9818-9827, Vol. 74, No. 21
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wirblich, C., Tan, G. S., Papaneri, A., Godlewski, P. J., Orenstein, J. M., Harty, R. N., Schnell, M. J.
(2008). PPEY Motif within the Rabies Virus (RV) Matrix Protein Is Essential for Efficient Virion Release and RV Pathogenicity. J. Virol.
82: 9730-9738
[Abstract]
[Full Text]
-
Swinteck, B. D., Lyles, D. S.
(2008). Plasma Membrane Microdomains Containing Vesicular Stomatitis Virus M Protein Are Separate from Microdomains Containing G Protein and Nucleocapsids. J. Virol.
82: 5536-5547
[Abstract]
[Full Text]
-
Okumura, A., Pitha, P. M., Harty, R. N.
(2008). ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. USA
105: 3974-3979
[Abstract]
[Full Text]
-
Taylor, G. M., Hanson, P. I., Kielian, M.
(2007). Ubiquitin Depletion and Dominant-Negative VPS4 Inhibit Rhabdovirus Budding without Affecting Alphavirus Budding. J. Virol.
81: 13631-13639
[Abstract]
[Full Text]
-
Irie, T., Carnero, E., Okumura, A., Garcia-Sastre, A., Harty, R. N.
(2007). Modifications of the PSAP region of the matrix protein lead to attenuation of vesicular stomatitis virus in vitro and in vivo. J. Gen. Virol.
88: 2559-2567
[Abstract]
[Full Text]
-
Urata, S., Noda, T., Kawaoka, Y., Morikawa, S., Yokosawa, H., Yasuda, J.
(2007). Interaction of Tsg101 with Marburg Virus VP40 Depends on the PPPY Motif, but Not the PT/SAP Motif as in the Case of Ebola Virus, and Tsg101 Plays a Critical Role in the Budding of Marburg Virus-Like Particles Induced by VP40, NP, and GP. J. Virol.
81: 4895-4899
[Abstract]
[Full Text]
-
Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R.
(2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol.
88: 1302-1314
[Abstract]
[Full Text]
-
Ciancanelli, M. J., Basler, C. F.
(2006). Mutation of YMYL in the Nipah Virus Matrix Protein Abrogates Budding and Alters Subcellular Localization. J. Virol.
80: 12070-12078
[Abstract]
[Full Text]
-
Lichty, B. D., McBride, H., Hanson, S., Bell, J. C.
(2006). Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motif.. J. Gen. Virol.
87: 3379-3384
[Abstract]
[Full Text]
-
Connor, J. H., McKenzie, M. O., Lyles, D. S.
(2006). Role of residues 121 to 124 of vesicular stomatitis virus matrix protein in virus assembly and virus-host interaction.. J. Virol.
80: 3701-3711
[Abstract]
[Full Text]
-
Urata, S., Noda, T., Kawaoka, Y., Yokosawa, H., Yasuda, J.
(2006). Cellular factors required for lassa virus budding.. J. Virol.
80: 4191-4195
[Abstract]
[Full Text]
-
Solon, J., Gareil, O., Bassereau, P., Gaudin, Y.
(2005). Membrane deformations induced by the matrix protein of vesicular stomatitis virus in a minimal system. J. Gen. Virol.
86: 3357-3363
[Abstract]
[Full Text]
-
Irie, T., Harty, R. N.
(2005). L-Domain Flanking Sequences Are Important for Host Interactions and Efficient Budding of Vesicular Stomatitis Virus Recombinants. J. Virol.
79: 12617-12622
[Abstract]
[Full Text]
-
Neumann, G., Ebihara, H., Takada, A., Noda, T., Kobasa, D., Jasenosky, L. D., Watanabe, S., Kim, J. H., Feldmann, H., Kawaoka, Y.
(2005). Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture. J. Virol.
79: 10300-10307
[Abstract]
[Full Text]
-
Stange, A., Mannigel, I., Peters, K., Heinkelein, M., Stanke, N., Cartellieri, M., Gottlinger, H., Rethwilm, A., Zentgraf, H., Lindemann, D.
(2005). Characterization of Prototype Foamy Virus Gag Late Assembly Domain Motifs and Their Role in Particle Egress and Infectivity. J. Virol.
79: 5466-5476
[Abstract]
[Full Text]
-
Schmitt, A. P., Leser, G. P., Morita, E., Sundquist, W. I., Lamb, R. A.
(2005). Evidence for a New Viral Late-Domain Core Sequence, FPIV, Necessary for Budding of a Paramyxovirus. J. Virol.
79: 2988-2997
[Abstract]
[Full Text]
-
Dong, B., Zhou, Q., Zhao, J., Zhou, A., Harty, R. N., Bose, S., Banerjee, A., Slee, R., Guenther, J., Williams, B. R. G., Wiedmer, T., Sims, P. J., Silverman, R. H.
(2004). Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon. J. Virol.
78: 8983-8993
[Abstract]
[Full Text]
-
Irie, T., Licata, J. M., Jayakar, H. R., Whitt, M. A., Bell, P., Harty, R. N.
(2004). Functional Analysis of Late-Budding Domain Activity Associated with the PSAP Motif within the Vesicular Stomatitis Virus M Protein. J. Virol.
78: 7823-7827
[Abstract]
[Full Text]
-
Irie, T., Licata, J. M., McGettigan, J. P., Schnell, M. J., Harty, R. N.
(2004). Budding of PPxY-Containing Rhabdoviruses Is Not Dependent on Host Proteins TGS101 and VPS4A. J. Virol.
78: 2657-2665
[Abstract]
[Full Text]
-
Shehu-Xhilaga, M., Ablan, S., Demirov, D. G., Chen, C., Montelaro, R. C., Freed, E. O.
(2004). Late Domain-Dependent Inhibition of Equine Infectious Anemia Virus Budding. J. Virol.
78: 724-732
[Abstract]
[Full Text]
-
Finke, S., Conzelmann, K.-K.
(2003). Dissociation of Rabies Virus Matrix Protein Functions in Regulation of Viral RNA Synthesis and Virus Assembly. J. Virol.
77: 12074-12082
[Abstract]
[Full Text]
-
Martin-Serrano, J., Bieniasz, P. D.
(2003). A Bipartite Late-Budding Domain in Human Immunodeficiency Virus Type 1. J. Virol.
77: 12373-12377
[Abstract]
[Full Text]
-
Martin-Serrano, J., Yarovoy, A., Perez-Caballero, D., Bieniasz, P. D.
(2003). Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. USA
100: 12414-12419
[Abstract]
[Full Text]
-
Strecker, T., Eichler, R., Meulen, J. t., Weissenhorn, W., Dieter Klenk, H., Garten, W., Lenz, O.
(2003). Lassa Virus Z Protein Is a Matrix Protein Sufficient for the Release of Virus-Like Particles. J. Virol.
77: 10700-10705
[Abstract]
[Full Text]
-
Yasuda, J., Nakao, M., Kawaoka, Y., Shida, H.
(2003). Nedd4 Regulates Egress of Ebola Virus-Like Particles from Host Cells. J. Virol.
77: 9987-9992
[Abstract]
[Full Text]
-
Goff, A., Ehrlich, L. S., Cohen, S. N., Carter, C. A.
(2003). Tsg101 Control of Human Immunodeficiency Virus Type 1 Gag Trafficking and Release. J. Virol.
77: 9173-9182
[Abstract]
[Full Text]
-
Gottwein, E., Bodem, J., Muller, B., Schmechel, A., Zentgraf, H., Krausslich, H.-G.
(2003). The Mason-Pfizer Monkey Virus PPPY and PSAP Motifs Both Contribute to Virus Release. J. Virol.
77: 9474-9485
[Abstract]
[Full Text]
-
Goila-Gaur, R., Demirov, D. G., Orenstein, J. M., Ono, A., Freed, E. O.
(2003). Defects in Human Immunodeficiency Virus Budding and Endosomal Sorting Induced by TSG101 Overexpression. J. Virol.
77: 6507-6519
[Abstract]
[Full Text]
-
Ahmed, M., McKenzie, M. O., Puckett, S., Hojnacki, M., Poliquin, L., Lyles, D. S.
(2003). Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis. J. Virol.
77: 4646-4657
[Abstract]
[Full Text]
-
Licata, J. M., Simpson-Holley, M., Wright, N. T., Han, Z., Paragas, J., Harty, R. N.
(2003). Overlapping Motifs (PTAP and PPEY) within the Ebola Virus VP40 Protein Function Independently as Late Budding Domains: Involvement of Host Proteins TSG101 and VPS-4. J. Virol.
77: 1812-1819
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Jeetendra, E., Robison, C. S., Albritton, L. M., Whitt, M. A.
(2002). The Membrane-Proximal Domain of Vesicular Stomatitis Virus G Protein Functions as a Membrane Fusion Potentiator and Can Induce Hemifusion. J. Virol.
76: 12300-12311
[Abstract]
[Full Text]
-
Rodriguez, L. L., Pauszek, S. J., Bunch, T. A., Schumann, K. R.
(2002). Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America. J. Gen. Virol.
83: 2475-2483
[Abstract]
[Full Text]
-
Jayakar, H. R., Whitt, M. A.
(2002). Identification of Two Additional Translation Products from the Matrix (M) Gene That Contribute to Vesicular Stomatitis Virus Cytopathology. J. Virol.
76: 8011-8018
[Abstract]
[Full Text]
-
Lee, K. J., Perez, M., Pinschewer, D. D., de la Torre, J. C.
(2002). Identification of the Lymphocytic Choriomeningitis Virus (LCMV) Proteins Required To Rescue LCMV RNA Analogs into LCMV-Like Particles. J. Virol.
76: 6393-6397
[Abstract]
[Full Text]
-
Strack, B., Calistri, A., Gottlinger, H. G.
(2002). Late Assembly Domain Function Can Exhibit Context Dependence and Involves Ubiquitin Residues Implicated in Endocytosis. J. Virol.
76: 5472-5479
[Abstract]
[Full Text]
-
Freed, E. O.
(2002). Viral Late Domains. J. Virol.
76: 4679-4687
[Full Text]
-
Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., Kawaoka, Y.
(2002). Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP. J. Virol.
76: 4855-4865
[Abstract]
[Full Text]
-
Patnaik, A., Chau, V., Li, F., Montelaro, R. C., Wills, J. W.
(2002). Budding of Equine Infectious Anemia Virus Is Insensitive to Proteasome Inhibitors. J. Virol.
76: 2641-2647
[Abstract]
[Full Text]
-
Patnaik, A., Wills, J. W.
(2002). In Vivo Interference of Rous Sarcoma Virus Budding by cis Expression of a WW Domain. J. Virol.
76: 2789-2795
[Abstract]
[Full Text]
-
Biacchesi, S., Bearzotti, M., Bouguyon, E., Bremont, M.
(2002). Heterologous Exchanges of the Glycoprotein and the Matrix Protein in a Novirhabdovirus. J. Virol.
76: 2881-2889
[Abstract]
[Full Text]
-
Muller, B., Patschinsky, T., Krausslich, H.-G.
(2002). The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles. J. Virol.
76: 1015-1024
[Abstract]
[Full Text]
-
Demirov, D. G., Orenstein, J. M., Freed, E. O.
(2002). The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner. J. Virol.
76: 105-117
[Abstract]
[Full Text]
-
Harty, R. N., Brown, M. E., McGettigan, J. P., Wang, G., Jayakar, H. R., Huibregtse, J. M., Whitt, M. A., Schnell, M. J.
(2001). Rhabdoviruses and the Cellular Ubiquitin-Proteasome System: a Budding Interaction. J. Virol.
75: 10623-10629
[Abstract]
[Full Text]
-
Kikonyogo, A., Bouamr, F., Vana, M. L., Xiang, Y., Aiyar, A., Carter, C., Leis, J.
(2001). Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA
10.1073/pnas.201268998v1
[Abstract]
[Full Text]
-
Reichert, M., Winnicka, A., Willems, L., Kettmann, R., Cantor, G. H.
(2001). Role of the Proline-Rich Motif of Bovine Leukemia Virus Transmembrane Protein gp30 in Viral Load and Pathogenicity in Sheep. J. Virol.
75: 8082-8089
[Abstract]
[Full Text]
-
Jasenosky, L. D., Neumann, G., Lukashevich, I., Kawaoka, Y.
(2001). Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer. J. Virol.
75: 5205-5214
[Abstract]
[Full Text]
-
Vogt, V. M.
(2000). Ubiquitin in retrovirus assembly: Actor or bystander?. Proc. Natl. Acad. Sci. USA
97: 12945-12947
[Full Text]
-
Kikonyogo, A., Bouamr, F., Vana, M. L., Xiang, Y., Aiyar, A., Carter, C., Leis, J.
(2001). Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc. Natl. Acad. Sci. USA
98: 11199-11204
[Abstract]
[Full Text]